Kocemba, David
Andersen, Peter Andreas
Carlsen, Jakob Gram
Schulz, Mette Katrine
Uhrbrand, Bent
Dinesen, Hanne
Mikkelsen, Ronni
Thygesen, Mathias
Rasmussen, Mikkel Mylius
Funding for this research was provided by:
Privat Hospitalet Mølholm, Johan Schrøders Fond, Dagmar Marshalls Fond, and A. P. Møller Fonden.
Article History
Received: 25 May 2025
Accepted: 3 December 2025
First Online: 12 December 2025
Declarations
:
: This study will be conducted according to the 2008 Declaration of Helsinki principles. It has been approved by the Central Denmark Region Research Ethics Committee (registration no. 1-10-72-79-23). The Danish Medicines Agency was consulted before study initiation, and it was determined that approval as a drug trial was not required (case no. 2023120319). Informed consent will be obtained from all participants before enrollment. Any protocol modifications that could impact study conduct, patient benefit, or treatment safety will require prior approval from the Central Denmark Region Research Ethics Committee.
: The authors declare no competing interests.
: Study personnel will obtain informed consent. The signed consent form, which is included in the appendix, will be uploaded to REDCap and stored securely at Aarhus University Hospital and Private Hospital Mølholm. All participants are informed and consent to the publication of study results prior to enrollment.